Tag: Presentation
Inventiva announces the presentation of a scientific abstract at the 83rd...
Daix (France), Long Island City (New York, United States), June 24, 2023 – Inventiva IVA, a clinical-stage biopharmaceutical company focused on the development...
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical...
Geron Corporation GERN, a late-stage clinical biopharmaceutical company, today announced that data from the pivotal IMerge Phase 3 clinical trial evaluating the Company's...
M-tron Industries, Inc. Announces Investor Presentation – M-Tron Industries (AME… –...
M-tron Industries, Inc. MPTI ("Company" or "MtronPTI") announced today that an investor presentation via live webcast hosted by members of the MtronPTI management...
Repare Therapeutics Announces Plenary Oral Presentation at the 2023 AACR Annual...
Repare Therapeutics Inc. ("Repare" or the "Company") RPTX, a leading clinical-stage precision oncology company, today announced the data from the Phase I/II trials...
Soroban Capital Partners Sends Letter and Presentation to Board of Directors...
Long-time UNP shareholder outlines UNP's significant underperformance during Lance Fritz's eight-year tenure as CEO
Believes experienced operational leadership will create significant value for shareholders...
Molecular Partners Announces Presentation of the EMPATHY Study of Ensovibep for...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 23, 2022 (GLOBE NEWSWIRE) -- Molecular Partners AG (MOLNMOLN, a clinical-stage biotech company developing a new class...
Franklin County Visitors Bureau Hosts Spring Into History Presentation: The U.S…....
Franklin County Visitors Bureau is celebrating Spring into History month with "The U.S. Constitution in the Words of Frederick Douglass," on April 30,...
Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Aca…...
The data provides further validation of the intended Phase 2 study designMELBOURNE, Australia and SAN FRANCISCO, April 6, 2022 /PRNewswire/ -- Alterity Therapeutics...
Sage Therapeutics Announces Presentation of Promising Results from the Phase 2...
Data to be Presented During the Emerging Science Session at the American Academy of Neurology's 74th Annual Meeting
The LUMINARY Study is a Phase...
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b...
Robust decreases in serum IgM at low- and mid-doses suggest best-in-class potential for mavorixafor plus ibrutinib therapy in double-mutation Waldenström’s patients; meaningful increases...